Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R-pramipexole in Early Alzheimer's Disease
NCT01388478Phase 2Completed
- Sponsor
- Virginia Commonwealth University
- Start
- Jul 2011
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dexpramipexole in Alzheimer's disease (AD), sponsored by Virginia Commonwealth University. Started Jul 2011; status: completed.
02
Drugs
dexpramipexole
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT01388478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01388478.